AbCellera Biologics (ABCL) has issued an announcement.
On August 6, 2024, during its earnings call, the Company will discuss the quarterly results up to June 30, 2024, while sharing a corporate presentation. The details provided in the presentation and the associated report are for informational purposes only and are not legally filed under the Securities Exchange Act, nor are they liable for legal scrutiny in the same way official filings are. They are also not part of any legal registration statements unless explicitly mentioned.
For detailed information about ABCL stock, go to TipRanks’ Stock Analysis page.
